CD8A and neoplasm: The superior effect of this combination therapy is associated with increased extracellular matrix (ECM) degradation, enhanced apoptosis, greater T-cell accumulation in tumor and spleen tissues, and elevated numbers of CD8+PD1− T cells (Yoon et al., 2024).